A Systematic Comparison From Specimen Acquisition To Diagnostic Value
Aug 27, 2026
https://www.chamfondbiotech.com/4-types-of-bone-marrow-biopsy-needles/
I. Microanatomical Basis and Examination Principles
1.1 Histological Composition of Bone Marrow
Bone marrow is the largest and most active hematopoietic organ in the human body, accounting for approximately 4%–5% of total body weight, with a total volume of about 2.6–4.0 kg (in a 70-kg adult). From a histological perspective, bone marrow consists of two core components:
Hematopoietic parenchymal cells: These include hematopoietic stem cells (HSCs), progenitor cells of various lineages, and mature blood cells at different stages of differentiation. Under physiological conditions, hematopoietic stem cells undergo asymmetric division to maintain self-renewal while differentiating along the myeloid (erythroid, granulocytic-monocytic, megakaryocytic) and lymphoid (T-cell, B-cell, NK-cell) pathways.
Hematopoietic microenvironment (HME): Composed of reticular cells, vascular endothelial cells, fibroblasts, adipocytes, extracellular matrix (collagen fibers, fibronectin, laminin, etc.), and nerve endings. This microenvironment secretes cytokines (e.g., SCF, TPO, G-CSF, IL-3) and provides physical scaffolding to finely regulate HSC homing, proliferation, and differentiation.
The vascular system within the bone marrow cavity is characterized by sinusoids - a network of thin-walled capillaries with widened endothelial gaps. Mature blood cells traverse the sinusoidal endothelium to enter the peripheral circulation. The structural integrity of these sinusoids directly affects whether aspirated specimens become diluted during bone marrow puncture, and also serves as an important morphological indicator for evaluating neovascularization and abnormal infiltration in biopsy specimens.
1.2 Dynamic Conversion Between Red Marrow and Yellow Marrow
|
Marrow Type |
Composition |
Distribution |
Functional Status |
|---|---|---|---|
|
Red marrow |
Hematopoietic cells ~40%–60%, adipocytes ~30%–50% |
Distributed throughout all bones in infancy; in adults, concentrated in the skull, sternum, ribs, vertebrae, pelvis, and proximal ends of femurs/humeri |
Active hematopoiesis; continuously produces all types of mature blood cells |
|
Yellow marrow |
Adipocytes predominate (>70%); very few hematopoietic cells |
Shafts of long bones in adults (e.g., distal femoral shaft) |
Quiescent state, but can undergo reverse conversion to red marrow ("yellow-to-red reversal") under pathological conditions such as severe anemia, marrow infiltration, or marrow necrosis |
Clinical correlation: On bone marrow biopsy sections, HE staining allows direct visual distinction between red marrow areas (cell-dense, darkly stained) and yellow marrow areas (fat vacuoles, lightly stained). Changes in this ratio (e.g., marrow cellularity grading) are key indicators for assessing hematopoietic reserve. Bone marrow aspiration smears cannot provide this spatial information.
1.3 Biological Rationale Behind the Two Examination Methods
The reason bone marrow aspiration and biopsy differ in diagnostic value lies in the fundamentally different dimensions of marrow they "see":
Bone marrow aspiration yields a dissociated suspension of free cells - the advantage is high-resolution morphological observation and cytochemical staining of individual cells; the disadvantage is the loss of the original spatial relationship of cells within the tissue (the "who's next to whom" information is lost).
Bone marrow biopsy yields a three-dimensional tissue section - it preserves the spatial relationship between cells and the microenvironment (the "neighborhood effect"), but at the cost of some loss of fine cellular detail due to fixation and sectioning.
The relationship between the two is analogous to "looking at a pile of loose LEGO bricks" (aspiration) versus "looking at a fully assembled LEGO model" (biopsy) - the former allows clear inspection of each brick's shape and color; the latter reveals the overall structure and assembly pattern. In clinical diagnosis, neither is dispensable.
II. Structural Differences in Operating Instruments
2.1 Design Principles of Bone Marrow Aspiration Needles
The most commonly used aspiration needles in clinical practice are the Jamshidi-modified or Roche-type needles. Their core components include:
|
Component |
Function |
|---|---|
|
Needle cannula (outer needle) |
A hollow metal tube with a beveled or pyramidal tip for penetrating the cortical bone; outer diameter typically 14–16 G (~1.6–2.1 mm) |
|
Stylet (inner core) |
A solid metal rod matching the inner diameter of the cannula; when inserted, it seals the needle tip bevel to prevent bone debris or tissue from clogging the lumen during insertion |
|
Depth stop (fixator) |
A sliding ring that can be locked along the cannula to preset insertion depth, preventing penetration through the opposite cortical plate (especially critical in sternal puncture) |
|
Needle hub and connector |
The terminal connection at the cannula tail for attaching a syringe during aspiration |
Working principle: After the needle penetrates the cortex and enters the medullary cavity, the stylet is removed and a dry syringe is attached to generate negative pressure, drawing marrow fluid into the syringe. The magnitude and duration of negative pressure directly affect specimen quality - excessive negative pressure or prolonged aspiration causes massive influx of sinusoidal blood, creating a "dilution artifact."
2.2 Design Principles of Bone Marrow Biopsy Needles
Bone marrow biopsy needles are divided into two major categories with distinctly different design philosophies:
(1) Trephine / Cutting Needles
Represented by the Jamshidi biopsy needle (currently the international standard):
|
Component |
Function |
|---|---|
|
Outer cannula (trocar) |
A metal tube with a sharp cutting edge at the tip; outer diameter typically 11–13 G (~2.4–3.0 mm) |
|
Inner stylet |
A solid rod with a tip slightly longer than the outer cannula; inserted first to penetrate the marrow and prevent tissue clogging |
|
Handle |
T-shaped or bow-shaped for two-handed rotational force application |
|
Depth markings |
Graduated scale on the cannula surface for visual depth reading |
Working principle: The inner stylet and outer cannula are rotated together into the marrow to a predetermined depth. The stylet is then withdrawn, and the outer cannula is rotated further to cut a short cylindrical core of bone marrow tissue, which is then withdrawn together with the cannula.
(2) Rotary Saw Needles (Biopsy punch)
Represented by the Islam biopsy needle, which uses a high-speed rotary cutting mechanism. These needles are less commonly used in clinical practice today and are occasionally employed for specific sites (e.g., sternal biopsy).
2.3 Biological and Clinical Significance of Needle Diameter Differences
|
Comparison |
Aspiration Needle (14–16 G) |
Biopsy Needle (11–13 G) |
|---|---|---|
|
Inner diameter |
~1.2–1.6 mm |
~2.0–2.8 mm |
|
Tissue trauma |
Minimal; puncture site requires virtually no suturing |
Slightly greater, but iliac crest biopsy also requires no suturing |
|
Pain level |
Mild (comparable to an intensified intramuscular injection) |
Somewhat more noticeable, but tolerable with adequate local anesthesia |
|
Specimen volume |
0.2–0.5 ml liquid |
1.5–2.0 cm long tissue core |
|
Impact on subsequent procedures |
Almost none |
Same puncture site should not be re-biopsied in the short term (allow ≥4–6 weeks between procedures) |
Technical note: The thicker design of the biopsy needle is not simply about "taking more material" - its core purpose is to ensure the tissue core diameter is large enough to preserve sufficient cell numbers and spatial architecture after sectioning. If the core is too thin (<1.5 mm diameter), it is highly prone to fragmentation or distortion during decalcification and sectioning, severely compromising diagnostic value.
III. Fundamental Differences in Specimen Acquisition and Processing
3.1 Bone Marrow Aspiration: Full Workflow of Liquid Specimen Cytological Analysis
(1) Technical Key Points of Aspiration
Syringe selection: A dry 10 ml syringe is recommended. Dryness is critical - even trace amounts of moisture can activate the coagulation cascade, causing the marrow sample to clot before smearing, resulting in a catastrophic "no cells to see" situation.
Aspiration volume control: 0.2–0.5 ml is optimal. Too little (<0.1 ml) may result in insufficient cell density on the smear; too much (>1.0 ml) causes excessive sinusoidal blood influx and peripheral blood dilution - the smear will show abundant mature lymphocytes and neutrophils, while the blast percentage is "diluted" downward, easily leading to false negatives or underestimation of disease burden.
Aspiration speed: Should be slow and steady to avoid excessive instantaneous negative pressure.
(2) Standardized Smear Preparation Workflow
|
Step |
Operational Details |
Quality Control Points |
|---|---|---|
|
Drop application |
Immediately reinsert stylet after aspiration; quickly place a drop of marrow fluid on a pre-labeled slide ~1 cm from one end |
From aspiration to smear completion should be within 30–60 seconds to prevent cell autolysis or clotting |
|
Spreading |
Assistant uses another slide as a spreader at a 30°–45° angle, lightly touching the drop and pushing forward at a steady speed |
Spreader speed determines smear thickness: faster = thinner; slower = thicker |
|
Number of slides |
Routinely prepare 5–8 smears; prepare an additional 3–5 if cytochemical stains (POX, PAS, NSE, etc.) are planned |
Insufficient slides are among the most common clinical problems |
|
Drying |
Air-dry naturally; never heat-dry (causes cell shrinkage and distortion) |
Send for processing immediately after drying |
(3) Staining Systems
Routine staining: Wright-Giemsa composite stain clearly displays nuclear chromatin patterns, nucleoli, cytoplasmic granules, and vacuoles.
Cytochemical staining: Includes peroxidase (POX), Sudan black B (SBB), non-specific esterase (NSE), specific esterase (CE), periodic acid-Schiff (PAS), and acid phosphatase (ACP) - critical for FAB classification of acute leukemias.
Iron staining: Prussian blue staining of marrow smears to assess intracellular and extracellular iron - the gold standard for diagnosing iron deficiency anemia and anemia of chronic disease.
3.2 Bone Marrow Biopsy: Full Workflow of Solid Specimen Histopathological Analysis
(1) Technical Key Points of Tissue Acquisition
Preferred site: Posterior superior iliac spine - thin cortex, abundant marrow, safe operation, and optimal core length and quality.
Insertion angle: Perpendicular to the bone surface, advanced with rotational motion.
Acquisition depth: Typically advance to 1.5–2.0 cm; deeper penetration increases pain without significantly increasing diagnostic information.
Core retrieval: After rotational cutting, withdraw the outer cannula with the core slowly. A small grayish-white strip of tissue (approximately sesame- to rice-grain-sized) will be visible at the needle tip.
(2) Critical Steps in Specimen Fixation
|
Step |
Operational Details |
Why It Matters |
|---|---|---|
|
Immediate fixation |
Place the core immediately into 10% neutral buffered formalin |
Delayed fixation causes cell autolysis and nuclear fragmentation, severely compromising morphological evaluation |
|
Fixation duration |
Room temperature for 4–24 hours (depending on core size) |
Under-fixation → tissue disintegration during decalcification; over-fixation → antigen masking, impairing immunohistochemistry |
|
Fixative volume |
Fixative volume should be 10–20 times the tissue volume |
Ensures complete penetration |
(3) Decalcification and Embedding
The most unique and challenging pre-processing step for bone marrow biopsy is decalcification:
Principle: Bone tissue contains abundant hydroxyapatite crystals, which must be dissolved by acidic decalcifying agents (e.g., EDTA, formic acid-formaldehyde mixtures) to soften the tissue to a sliceable state.
Method selection:
EDTA decalcification (recommended): Chelating action is gentle, preserves tissue antigens and DNA well, suitable for downstream IHC and molecular testing; disadvantage is prolonged duration (3–7 days).
Acid rapid decalcification (e.g., nitric acid method): Fast (several hours) but causes significant damage to antigens and nucleic acids, potentially affecting downstream assays.
Paraffin embedding: After decalcification, the tissue undergoes gradient alcohol dehydration, xylene clearing, paraffin infiltration, and embedding into a paraffin block.
(4) Sectioning and Staining
|
Stain Type |
Specific Methods |
Diagnostic Use |
|---|---|---|
|
Routine stains |
HE stain, Giemsa stain |
Assess cellular density, fat proportion, abnormal cell infiltration patterns |
|
Fibrosis evaluation |
Gomori silver stain (reticulin), Masson's trichrome |
Bone marrow fibrosis grading (MF-0 to MF-3) |
|
Immunohistochemistry (IHC) |
CD34, CD117, MPO, CD3, CD20, CD138, etc. |
Determine abnormal cell lineage, assess minimal residual disease |
|
Special stains |
Congo red (amyloidosis), PAS (fungi/mucin) |
Confirm specific pathological conditions |
IV. In-Depth Comparison of Diagnostic Advantages
4.1 Unique Advantages of Bone Marrow Aspiration - Deep Analysis
(1) Single-Cell Resolution Morphological Diagnosis
The greatest strength of marrow smears is that each cell is "spread apart" - with good spreading technique, cells are arranged in a single monolayer without overlap. This enables the pathologist to examine every cell under oil immersion (1000×) for:
Nuclear chromatin coarseness and distribution patterns
Number, size, and prominence of nucleoli
Cytoplasmic color, granule types (azurophilic, neutrophilic, eosinophilic, etc.)
Cell size and morphological regularity
This "cell-level" resolution is unattainable with biopsy sections - in 3–5 μm thick tissue sections, nuclei frequently overlap vertically, cytoplasmic details are compressed, and precise classification of individual cells is extremely difficult.
(2) Detailed Megakaryocyte Assessment
Megakaryocytes are the largest cells in the marrow (up to 50–100 μm in diameter). Morphological abnormalities are diagnostically crucial for several disorders:
|
Abnormality |
Morphological Features |
Associated Disease |
|---|---|---|
|
Giant forms |
Cell body >100 μm, excessive lobulation (>10 lobes) |
Megaloblastic anemia (B12/folate deficiency) |
|
Megaloblastoid change |
Enlarged cell body but limited lobulation; nuclear maturation lags behind cytoplasm |
MDS, megaloblastic anemia |
|
Micromegakaryocytes |
Small cell body (comparable to lymphocytes), unlobated or minimally lobulated nucleus |
MDS (especially 5q- syndrome), AML with recurrent genetic abnormalities |
On smears, these abnormalities are readily apparent; in biopsy sections, megakaryocytes are often obscured by other cells and their full morphology is difficult to appreciate due to section thickness limitations.
(3) Quantifiable Value of Cytochemical Stains
Cytochemical staining results on marrow smears can be precisely quantified - for example, POX positivity rate is expressed as a percentage (e.g., "blast POX positivity 85%"), which is a core criterion for distinguishing AML from ALL. In biopsy sections, enzyme activity and chromogen deposition are affected by fixation and decalcification, yielding only semi-quantitative results ("weakly positive" or "focally positive"), without precise numerical values.
4.2 Unique Advantages of Bone Marrow Biopsy - Deep Analysis
(1) Spatial Proportion of Hematopoietic vs. Fatty Tissue
In biopsy sections, the ratio of red marrow (hematopoietic area) to yellow marrow (fatty area) can be directly visualized and quantified. Normal adult marrow contains approximately 30%–50% hematopoietic tissue and 50%–70% fat. Alterations in this ratio carry significant diagnostic implications:
|
Pathological State |
Red/Yellow Marrow Ratio Change |
Clinical Significance |
|---|---|---|
|
Aplastic anemia |
Red marrow drastically reduced (<10%), nearly entirely replaced by fat |
Core criterion for confirming aplastic anemia |
|
Myelodysplastic syndrome |
Red marrow increased (50%–80%), with abnormal localization (ALIP phenomenon) |
Supports MDS diagnosis |
|
Myelofibrosis |
Red marrow replaced by dense fibrous tissue |
Required for PMF diagnosis |
|
Leukemic infiltration |
Red marrow almost completely occupied by a monomorphic population of leukemic cells |
Assesses tumor burden |
(2) Precise Evaluation of Nucleated Cell Density
Biopsy sections allow calculation of nucleated cell count per square millimeter or use of a semi-quantitative cellularity grading system (5-tier):
|
Cellularity Grade |
Nucleated Cell Proportion |
Corresponding Pathological State |
|---|---|---|
|
Extremely hypercellular |
>90% |
CML blast phase, some AML |
|
Markedly hypercellular |
70%–90% |
CML chronic phase, PV, ET |
|
Cellular (normal) |
30%–70% |
Normal or mildly abnormal |
|
Hypocellular |
10%–30% |
Some MDS, post-treatment states |
|
Severely hypocellular |
<10% |
Severe aplastic anemia |
This biopsy-based cellularity assessment is more objective than smear evaluation - smears only reflect cell density in "the tiny fraction that was aspirated," whereas biopsy reveals the "full panorama" of the entire marrow cavity.
(3) Avoidance of Sinusoidal Dilution - Truly Reflecting Hematopoietic Status
During aspiration, negative pressure inevitably draws sinusoidal blood along with marrow fluid, causing some degree of dilution. Although experienced operators can minimize this by controlling aspiration volume, it cannot be completely eliminated. Biopsy tissue cores, by contrast, are not subject to sinusoidal dilution - sinusoidal blood is washed away during fixation, and the cells seen on the section are exclusively parenchymal marrow cells. This is especially important in evaluating hypocellular MDS or early myelofibrosis.
(4) Diagnostic Value for Specific Diseases
|
Disease |
Diagnostic Role of Biopsy |
Mechanistic Explanation |
|---|---|---|
|
Primary Myelofibrosis (PMF) |
Gold standard for diagnosis |
Smears cannot show fibrosis degree; reticulin staining on biopsy confirms MF grading |
|
Hairy Cell Leukemia (HCL) |
Characteristic diagnosis |
Biopsy reveals "fried-egg" hairy cell infiltrates and prominent reticulin fibrosis; smears may miss HCL cells |
|
MDS to AML progression |
Early warning |
Biopsy can demonstrate emergence and expansion of abnormal localization of immature precursors (ALIP), preceding abundant blasts on smears |
|
Lymphoma marrow involvement |
Infiltration pattern determination |
Distinguishes nodular, interstitial, mixed, and diffuse patterns - critical for staging and treatment decisions |
|
Metastatic tumors |
Diagnostic confirmation |
Clearly shows epithelial tumor nests or metastatic melanoma; IHC identifies primary site |
(5) Differential Diagnosis of "Dry Tap" - The Irreplaceable Role of Biopsy
A "dry tap" is defined as: the aspiration needle has clearly entered the marrow cavity, but repeated attempts yield no fluid. Common causes and the diagnostic value of biopsy:
|
Cause of Dry Tap |
Biopsy Findings |
Diagnostic Significance |
|---|---|---|
|
Myelofibrosis |
Abundant reticulin fibers; marrow cavity filled with collagen |
Confirms PMF or secondary myelofibrosis |
|
Extensive malignant infiltration |
Marrow cavity packed with metastatic carcinoma or melanoma cells, crowding out normal hematopoiesis |
Identifies metastasis source (requires IHC) |
|
Extreme leukemic hypercellularity |
Marrow cavity almost entirely filled with dense leukemic cells; extremely high viscosity |
Confirms AML/ALL (combined with any微量 smear obtained) |
|
Marrow necrosis |
Amorphous eosinophilic material and nuclear debris throughout the tissue |
Suggests severe infection, DIC, or tumor lysis |
|
Technical factors |
Histologically normal hematopoiesis |
Excludes pathological causes; repeat aspiration at a different site |
V. Limitations Compared - Deep Analysis
5.1 Limitations of Bone Marrow Aspiration
(1) Destruction of Natural Architecture - Loss of the "Cellular Social Network"
Aspiration disperses bone marrow tissue into a single-cell suspension. While this facilitates individual cell examination, it means complete loss of spatial relationship information between cells, including:
Inability to determine whether blasts are clustered (ALIP phenomenon)
Inability to assess reticulin fiber proliferation
Inability to distinguish boundaries between hematopoietic and fatty zones
This information is precisely what is most critical in diagnosing MDS and myelofibrosis.
(2) Sinusoidal Dilution - The Risk of "Watering Down"
Even in the most experienced hands, aspirate specimens inevitably contain some proportion of sinusoidal blood. Studies indicate that approximately 10%–30% of cells in routine marrow aspirate smears originate from sinusoidal dilution. This dilution effect is particularly pronounced in:
Over-aspiration (>1 ml)
Overly rapid aspiration
Patients with significant hypersplenism (accelerated sinusoidal flow)
Intrinsically hypocellular marrow (fewer normal cells, higher dilution ratio)
The consequence: blast percentages are underestimated, potentially misclassifying high-risk MDS as low-risk, or missing an AML diagnosis entirely.
(3) Dry Tap - The "Dead End" of Examination Failure
As described above, when a dry tap occurs, aspiration yields no valid specimen. Without a subsequent biopsy, the patient faces a prolonged diagnostic gap and potentially the additional pain of repeat procedures.
5.2 Limitations of Bone Marrow Biopsy
(1) Difficulty in Cell Type Identification - "Facial Blindness in a Crowd"
In 3–5 μm thick tissue sections, nuclei overlap vertically and cytoplasm is compressed, leading to:
Difficulty distinguishing myeloblasts from monoblasts (POX staining on smears resolves this)
Occasional inability to differentiate erythroid precursors from lymphocytes
Extreme difficulty in identifying micromegakaryocytes
Thus, while biopsy can tell you "there are many densely packed cells here," it cannot precisely tell you what those cells actually are.
(2) Limited Visualization of Fine Intracellular Structures - "Insufficient Pixel Resolution"
Processing steps - fixation (formalin), decalcification (acidic environment), and embedding (heated paraffin) - cause some degree of cell shrinkage and distortion:
Nucleoli may become indistinct or disappear
Cytoplasmic granules may dissolve or shift position
Auer rods (characteristic of AML) are extremely difficult to identify in sections
On smears, these fine structures are clearly visible in freshly fixed or near-living cells.
(3) Difficulty Quantifying Cytochemical Stains - "Qualitative but Not Quantitative"
As noted, enzyme activity and antigen preservation in biopsy sections are affected by processing. Cytochemical staining results are mostly semi-quantitative (e.g., "positive" or "weakly positive"), lacking the precise percentage values achievable on smears. This is a clear shortcoming in the precise subtyping of acute leukemias.
VI. Complementary Relationship in Clinical Decision-Making - From Guidelines to Practice
6.1 Recommendations from Major Guidelines
|
Guideline Source |
Recommendation |
|---|---|
|
WHO Classification of Haematolymphoid Tumours (2016/2022) |
For MDS, MPN, AML, etc., simultaneous aspiration and biopsy are recommended; combined use increases diagnostic accuracy by 15%–25% |
|
NCCN MDS Guidelines |
Bone marrow biopsy is mandatory for initial MDS diagnosis to assess blast percentage, fibrosis degree, and ALIP |
|
Chinese Expert Consensus on Aplastic Anemia |
Biopsy is essential for aplastic anemia diagnosis; smears alone cannot substitute |
|
ELN AML Guidelines |
Aspirate smears are central to AML diagnosis and classification; biopsy serves as a supplement (especially for fibrosis, angiogenesis, and MRD assessment) |
6.2 Standardized "One Puncture, One Biopsy" Strategy
Major international hematology centers widely adopt the strategy of single anesthesia, single puncture site (posterior superior iliac spine), sequential aspiration followed by biopsy:
|
Step |
Order |
Rationale |
|---|---|---|
|
Step 1 |
Perform aspiration first |
Performing biopsy first may cause local bleeding and fibrosis, reducing subsequent aspiration success |
|
Step 2 |
Perform biopsy second |
Changes from aspiration have minimal impact on biopsy (which evaluates tissue architecture; minor bleeding does not affect overall assessment) |
|
Step 3 |
Same puncture site |
Reduces patient discomfort; both specimens come from the same anatomical location, directly comparable |
6.3 Disease-Specific Selection Strategy
|
Clinical Scenario |
Primary Test |
Secondary/Adjunct |
Rationale |
|---|---|---|---|
|
Newly diagnosed acute leukemia |
Aspiration smear |
Biopsy (optional) |
Smear sufficient for FAB classification and immunophenotyping; biopsy for fibrosis/angiogenesis |
|
Suspected myelofibrosis |
Biopsy |
Smear (adjunct) |
Biopsy is the only definitive diagnostic modality |
|
Suspected MDS |
Both simultaneously |
- |
WHO criteria require both |
|
Aplastic anemia |
Biopsy |
Smear (adjunct) |
Fat replacement assessment is key to diagnosis |
|
Lymphoma staging |
Biopsy |
Smear (adjunct) |
Biopsy shows infiltration pattern; smear may miss focal involvement |
|
Multiple myeloma |
Both simultaneously |
- |
Smear for plasma cell morphology; biopsy for plasma cell clustering and fibrosis |
|
Metastatic cancer workup |
Biopsy |
Smear (adjunct) |
IHC on biopsy identifies primary site; smear only occasionally reveals tumor cells |
6.4 Insight from a Typical Case
Case: Male, 68 years old, progressive fatigue and splenomegaly. CBC: Hb 82 g/L, WBC 4.2×10⁹/L, PLT 58×10⁹/L. Peripheral smear shows occasional teardrop cells.
Aspiration alone: Might yield a slightly diluted specimen showing "hypocellularity with few abnormal cells" - insufficient for definitive diagnosis; could be misdiagnosed as "hypocellular MDS."
Biopsy alone: Would show marked fibrosis and clustered blasts, suggesting PMF, but precise blast classification would be impossible.
Combined: Smear shows left-shifted granulopoiesis with immature myeloid cells; biopsy shows MF-2 fibrosis, positive ALIP, and abnormal megakaryocyte morphology - comprehensive diagnosis: primary myelofibrosis (prefibrotic/early stage) with MDS features, providing a precise basis for subsequent treatment.








